Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Craig

Showing results (501-510 of 549) with videos related to

Pageof 55
Sort By:
Journal of the National Cancer Institute|January 16, 1991
Phase I clinical and pharmacokinetic trial of flavone acetic acidK A Havlin, J G Kuhn, J B Craig, et al.
Cancer|April 15, 1990
A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association StudyD R White, B L Powell, J B Craig, et al.
Selective Cancer Therapeutics|January 1, 1991
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion scheduleP W Cobb, K A Havlin, J G Kuhn, et al.
Zoonoses and Public Health|August 26, 2018
Determinants of clinical leptospirosis in NepalRupesh Shrestha, Joanna S McKenzie, Milan Gautam, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignanciesB L Powell, H B Muss, R L Capizzi, et al.
Journal of Acquired Immune Deficiency Syndromes|January 11, 1992
Predictors of HIV-1 disease progression in early- and late-stage patients: the U.S. Army Natural History Cohort. Military Medical Consortium for Applied RetrovirologyL I Gardner, J F Brundage, J G McNeil, et al.
Cancer Research|August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose scheduleG S Harman, J B Craig, J G Kuhn, et al.
Vaccines|August 6, 2021
Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing ActivitySeth H Pincus, Ryan B Craig, Lauren Weachter, et al.
American Journal of Clinical Oncology|October 1, 1988
Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association StudyB L Powell, J B Craig, H B Muss, et al.
American Journal of Obstetrics and Gynecology|April 29, 2019
To the point: undergraduate medical education learner mistreatment issues on the learning environment in the United StatesArchana Pradhan, Samantha D Buery-Joyner, Sarah Page-Ramsey, et al.
Pageof 55

Showing results (501-510 of 549) with videos related to

Sort By:
Pageof 55
Journal of the National Cancer Institute|January 16, 1991
Phase I clinical and pharmacokinetic trial of flavone acetic acidK A Havlin, J G Kuhn, J B Craig, et al.
Cancer|April 15, 1990
A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association StudyD R White, B L Powell, J B Craig, et al.
Selective Cancer Therapeutics|January 1, 1991
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion scheduleP W Cobb, K A Havlin, J G Kuhn, et al.
Zoonoses and Public Health|August 26, 2018
Determinants of clinical leptospirosis in NepalRupesh Shrestha, Joanna S McKenzie, Milan Gautam, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignanciesB L Powell, H B Muss, R L Capizzi, et al.
Journal of Acquired Immune Deficiency Syndromes|January 11, 1992
Predictors of HIV-1 disease progression in early- and late-stage patients: the U.S. Army Natural History Cohort. Military Medical Consortium for Applied RetrovirologyL I Gardner, J F Brundage, J G McNeil, et al.
Cancer Research|August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose scheduleG S Harman, J B Craig, J G Kuhn, et al.
Vaccines|August 6, 2021
Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing ActivitySeth H Pincus, Ryan B Craig, Lauren Weachter, et al.
American Journal of Clinical Oncology|October 1, 1988
Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association StudyB L Powell, J B Craig, H B Muss, et al.
American Journal of Obstetrics and Gynecology|April 29, 2019
To the point: undergraduate medical education learner mistreatment issues on the learning environment in the United StatesArchana Pradhan, Samantha D Buery-Joyner, Sarah Page-Ramsey, et al.
Pageof 55